Selected research
Industry Research
Medication for Dental Industry Research Report 2026
Market perspective
The global Medication for Dental market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Medication for Dental market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Medication for Dental market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Medication for Dental market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Medication for Dental include Teva, Sun Pharmaceutical, Johnson & Johnson, Qilu Pharmaceutical, Novartis, Mylan, GSK, Bayer and Lupin, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Medication for Dental market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Medication for Dental.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medication for Dental Market by Company
Teva
Sun Pharmaceutical
Johnson & Johnson
Qilu Pharmaceutical
Novartis
Mylan
GSK
Bayer
Lupin
Lingrui
Galderma
Dr. Reddy's
CR SANJIU
Cipla
Bausch Health
Aurobindo
Almirall
Medication for Dental Segment by Type
NSAID
OTC Analgesic Medications
Opioid
Medication for Dental Segment by Application
Drug Store
Hospital
Other
Medication for Dental Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medication for Dental market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medication for Dental and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medication for Dental.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medication for Dental companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NSAID
- OTC Analgesic Medications
- Opioid
Applications
- Drug Store
- Hospital
- Other
Companies covered
- Teva
- Sun Pharmaceutical
- Johnson & Johnson
- Qilu Pharmaceutical
- Novartis
- Mylan
- GSK
- Bayer
- Lupin
- Lingrui
- Galderma
- Dr. Reddy's
- CR SANJIU
- Cipla
- Bausch Health
- Aurobindo
- Almirall
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medication for Dental by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 NSAID
- 2.2.3 OTC Analgesic Medications
- 2.2.4 Opioid
- 2.3 Medication for Dental by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Store
- 2.3.3 Hospital
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Medication for Dental Breakdown Data by Type
- 3.1 Global Medication for Dental Historic Market Size by Type (2021-2026)
- 3.2 Global Medication for Dental Forecasted Market Size by Type (2027-2032)
4 Medication for Dental Breakdown Data by Application
- 4.1 Global Medication for Dental Historic Market Size by Application (2021-2026)
- 4.2 Global Medication for Dental Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Medication for Dental Market Perspective (2021-2032)
- 5.2 Global Medication for Dental Growth Trends by Region
- 5.2.1 Global Medication for Dental Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Medication for Dental Historic Market Size by Region (2021-2026)
- 5.2.3 Medication for Dental Forecasted Market Size by Region (2027-2032)
- 5.3 Medication for Dental Market Dynamics
- 5.3.1 Medication for Dental Industry Trends
- 5.3.2 Medication for Dental Market Drivers
- 5.3.3 Medication for Dental Market Challenges
- 5.3.4 Medication for Dental Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Medication for Dental Players by Revenue
- 6.1.1 Global Top Medication for Dental Players by Revenue (2021-2026)
- 6.1.2 Global Medication for Dental Revenue Market Share by Players (2021-2026)
- 6.2 Global Medication for Dental Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Medication for Dental Head Office and Area Served
- 6.4 Global Medication for Dental Players, Product Type & Application
- 6.5 Global Medication for Dental Manufacturers Established Date
- 6.6 Global Medication for Dental Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Medication for Dental Market Size (2021-2032)
- 7.2 North America Medication for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Medication for Dental Market Size by Country (2021-2026)
- 7.4 North America Medication for Dental Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Medication for Dental Market Size (2021-2032)
- 8.2 Europe Medication for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Medication for Dental Market Size by Country (2021-2026)
- 8.4 Europe Medication for Dental Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Medication for Dental Market Size (2021-2032)
- 9.2 Asia-Pacific Medication for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Medication for Dental Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Medication for Dental Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Medication for Dental Market Size (2021-2032)
- 10.2 South America Medication for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Medication for Dental Market Size by Country (2021-2026)
- 10.4 South America Medication for Dental Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Medication for Dental Market Size (2021-2032)
- 11.2 Middle East & Africa Medication for Dental Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Medication for Dental Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Medication for Dental Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva
- 12.1.1 Teva Company Information
- 12.1.2 Teva Business Overview
- 12.1.3 Teva Revenue in Medication for Dental Business (2021-2026)
- 12.1.4 Teva Medication for Dental Product Portfolio
- 12.1.5 Teva Recent Developments
- 12.2 Sun Pharmaceutical
- 12.2.1 Sun Pharmaceutical Company Information
- 12.2.2 Sun Pharmaceutical Business Overview
- 12.2.3 Sun Pharmaceutical Revenue in Medication for Dental Business (2021-2026)
- 12.2.4 Sun Pharmaceutical Medication for Dental Product Portfolio
- 12.2.5 Sun Pharmaceutical Recent Developments
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Information
- 12.3.2 Johnson & Johnson Business Overview
- 12.3.3 Johnson & Johnson Revenue in Medication for Dental Business (2021-2026)
- 12.3.4 Johnson & Johnson Medication for Dental Product Portfolio
- 12.3.5 Johnson & Johnson Recent Developments
- 12.4 Qilu Pharmaceutical
- 12.4.1 Qilu Pharmaceutical Company Information
- 12.4.2 Qilu Pharmaceutical Business Overview
- 12.4.3 Qilu Pharmaceutical Revenue in Medication for Dental Business (2021-2026)
- 12.4.4 Qilu Pharmaceutical Medication for Dental Product Portfolio
- 12.4.5 Qilu Pharmaceutical Recent Developments
- 12.5 Novartis
- 12.5.1 Novartis Company Information
- 12.5.2 Novartis Business Overview
- 12.5.3 Novartis Revenue in Medication for Dental Business (2021-2026)
- 12.5.4 Novartis Medication for Dental Product Portfolio
- 12.5.5 Novartis Recent Developments
- 12.6 Mylan
- 12.6.1 Mylan Company Information
- 12.6.2 Mylan Business Overview
- 12.6.3 Mylan Revenue in Medication for Dental Business (2021-2026)
- 12.6.4 Mylan Medication for Dental Product Portfolio
- 12.6.5 Mylan Recent Developments
- 12.7 GSK
- 12.7.1 GSK Company Information
- 12.7.2 GSK Business Overview
- 12.7.3 GSK Revenue in Medication for Dental Business (2021-2026)
- 12.7.4 GSK Medication for Dental Product Portfolio
- 12.7.5 GSK Recent Developments
- 12.8 Bayer
- 12.8.1 Bayer Company Information
- 12.8.2 Bayer Business Overview
- 12.8.3 Bayer Revenue in Medication for Dental Business (2021-2026)
- 12.8.4 Bayer Medication for Dental Product Portfolio
- 12.8.5 Bayer Recent Developments
- 12.9 Lupin
- 12.9.1 Lupin Company Information
- 12.9.2 Lupin Business Overview
- 12.9.3 Lupin Revenue in Medication for Dental Business (2021-2026)
- 12.9.4 Lupin Medication for Dental Product Portfolio
- 12.9.5 Lupin Recent Developments
- 12.10 Lingrui
- 12.10.1 Lingrui Company Information
- 12.10.2 Lingrui Business Overview
- 12.10.3 Lingrui Revenue in Medication for Dental Business (2021-2026)
- 12.10.4 Lingrui Medication for Dental Product Portfolio
- 12.10.5 Lingrui Recent Developments
- 12.11 Galderma
- 12.11.1 Galderma Company Information
- 12.11.2 Galderma Business Overview
- 12.11.3 Galderma Revenue in Medication for Dental Business (2021-2026)
- 12.11.4 Galderma Medication for Dental Product Portfolio
- 12.11.5 Galderma Recent Developments
- 12.12 Dr. Reddy's
- 12.12.1 Dr. Reddy's Company Information
- 12.12.2 Dr. Reddy's Business Overview
- 12.12.3 Dr. Reddy's Revenue in Medication for Dental Business (2021-2026)
- 12.12.4 Dr. Reddy's Medication for Dental Product Portfolio
- 12.12.5 Dr. Reddy's Recent Developments
- 12.13 CR SANJIU
- 12.13.1 CR SANJIU Company Information
- 12.13.2 CR SANJIU Business Overview
- 12.13.3 CR SANJIU Revenue in Medication for Dental Business (2021-2026)
- 12.13.4 CR SANJIU Medication for Dental Product Portfolio
- 12.13.5 CR SANJIU Recent Developments
- 12.14 Cipla
- 12.14.1 Cipla Company Information
- 12.14.2 Cipla Business Overview
- 12.14.3 Cipla Revenue in Medication for Dental Business (2021-2026)
- 12.14.4 Cipla Medication for Dental Product Portfolio
- 12.14.5 Cipla Recent Developments
- 12.15 Bausch Health
- 12.15.1 Bausch Health Company Information
- 12.15.2 Bausch Health Business Overview
- 12.15.3 Bausch Health Revenue in Medication for Dental Business (2021-2026)
- 12.15.4 Bausch Health Medication for Dental Product Portfolio
- 12.15.5 Bausch Health Recent Developments
- 12.16 Aurobindo
- 12.16.1 Aurobindo Company Information
- 12.16.2 Aurobindo Business Overview
- 12.16.3 Aurobindo Revenue in Medication for Dental Business (2021-2026)
- 12.16.4 Aurobindo Medication for Dental Product Portfolio
- 12.16.5 Aurobindo Recent Developments
- 12.17 Almirall
- 12.17.1 Almirall Company Information
- 12.17.2 Almirall Business Overview
- 12.17.3 Almirall Revenue in Medication for Dental Business (2021-2026)
- 12.17.4 Almirall Medication for Dental Product Portfolio
- 12.17.5 Almirall Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst